Cassava Sciences Inc vs Roundhill Russell 2000 0DTE Covered Call Strat ETF — how do they compare? Cassava Sciences Inc trades at $0.81 (market cap $39.40M), while Roundhill Russell 2000 0DTE Covered Call Strat ETF trades at $26.04 (market cap $159.33M). The key difference: Roundhill Russell 2000 0DTE Covered Call Strat ETF is far larger — about 4× Cassava Sciences Inc's market cap, and Cassava Sciences Inc is more actively traded (759,018 versus 248,058). Which is the better fit depends on your goals — on Pluang, investors hold Cassava Sciences Inc for 37 Days and Roundhill Russell 2000 0DTE Covered Call Strat ETF for 53 Days on average.
| FLNA | RDTE | |
|---|---|---|
Market Cap | $39.40M | $159.33M |
Volume | 759,018 | 248,058 |
Sector | Health | Income / Options Overlay |
52-Week High | $4.64 | $33.66 |
52-Week Low | $0.68 | $25.96 |
Typical Hold Time | 37 Days | 53 Days |
Enterprise Value | -$43.28M | — |
Signals from Pluang's Aura AI — not financial advice
Filana Therapeutics (FLNA) trades at $0.82, down 6.77% today, amid bearish technical signals but with positive fundamental catalysts. The company shows improving quarterly EPS beats and a favorable EV/EBITDA of 1.03, though it remains unprofitable with negative cash flow. Recent FDA clearance for its epilepsy drug trial has generated optimism, reflected in strong analyst buy ratings (67% consensus).
The outlook balances clinical progress against financial strain. The FDA hold lift on simufilam provides a clear near-term catalyst for Phase 2a trials starting in 2027, supporting the bullish analyst view. However, high cash burn (-$33M net CF in 2025) and lack of revenue pose significant risks to sustainability, requiring careful monitoring of funding and trial milestones.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →RDTE is an actively managed ETF that seeks to generate income through a covered call strategy on the Russell 2000 Index. The fund primarily holds a portfolio of short-term U.S. government securities and sells 0-DTE (zero days to expiration) index call options on the Russell 2000. This highly tactical strategy aims to maximize premium capture by exploiting the high time decay of options that are expiring on the same day, which provides enhanced income but also exposes the fund to significant volatility and risks associated with daily options settlement.
Read more on RDTE →